Stock listing
Hamburg:OCD1 Niagen Bioscience, Inc. Aktie
German listing (Hamburg) of Niagen Bioscience, Inc. · home listing NASDAQ:NAGE
Follow Niagen Bioscience, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NAGE
$2.33 USD -0.17 (-6.8%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NAGE
- Day range
- $2.32 – $2.49 USDOct 30, 2026
- Volume
- 519,562 sharesOct 30, 2026
- Market cap
- $184.4M USDAt the close on Oct 30, 2026 · price × 79.13M shares outstanding
- 52-week range
- $2.32 – $7.95 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.58M USDMedian day 469,935 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NAGE · Home | $2.33 USD | -0.17 (-6.8%) | 519,562 | $2.49 | $2.49 | $2.32 | $2.50 | Close on Oct 30, 2026 |
| Frankfurt:OCD1 | €1.80 EUR | +0.06 (+3.4%) | — | €1.80 | €1.80 | €1.80 | €1.74 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NAGE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.33 | -0.17 | -6.8% | $2.49 | $2.49 | $2.32 | 519,562 | |
| $2.50 | -0.04 | -1.6% | $2.58 | $2.58 | $2.50 | 343,686 | |
| $2.54 | +0.04 | +1.6% | $2.49 | $2.55 | $2.47 | 363,911 | |
| $2.50 | +0.06 | +2.5% | $2.46 | $2.51 | $2.425 | 473,469 | |
| $2.44 | +0.01 | +0.4% | $2.43 | $2.45 | $2.385 | 405,770 | |
| $2.43 | -0.09 | -3.6% | $2.50 | $2.50 | $2.42 | 543,200 | |
| $2.52 | +0.05 | +2.0% | $2.46 | $2.53 | $2.46 | 502,400 | |
| $2.47 | -0.04 | -1.6% | $2.52 | $2.52 | $2.43 | 652,300 | |
| $2.51 | +0.01 | +0.4% | $2.50 | $2.54 | $2.48 | 517,600 | |
| $2.50 | +0.01 | +0.4% | $2.49 | $2.52 | $2.44 | 508,800 | |
| $2.49 | -0.09 | -3.5% | $2.58 | $2.59 | $2.46 | 555,800 | |
| $2.58 | +0.05 | +2.0% | $2.55 | $2.60 | $2.53 | 444,200 | |
| $2.53 | -0.05 | -1.9% | $2.55 | $2.59 | $2.51 | 522,900 | |
| $2.58 | -0.05 | -1.9% | $2.63 | $2.64 | $2.55 | 636,500 | |
| $2.63 | -0.06 | -2.2% | $2.67 | $2.68 | $2.60 | 407,800 | |
| $2.69 | +0.03 | +1.1% | $2.68 | $2.71 | $2.67 | 268,100 | |
| $2.66 | -0.06 | -2.2% | $2.71 | $2.71 | $2.61 | 635,100 | |
| $2.72 | +0.03 | +1.1% | $2.67 | $2.76 | $2.65 | 361,100 | |
| $2.69 | +0.01 | +0.4% | $2.67 | $2.71 | $2.66 | 373,200 | |
| $2.68 | -0.11 | -3.9% | $2.79 | $2.79 | $2.67 | 864,800 | |
| $2.79 | +0.11 | +4.1% | $2.72 | $2.80 | $2.61 | 1,568,300 | |
| $2.68 | -0.24 | -8.2% | $2.91 | $2.92 | $2.67 | 1,385,000 | |
| $2.92 | -0.03 | -1.0% | $2.97 | $2.98 | $2.91 | 360,500 | |
| $2.95 | -0.03 | -1.0% | $3.00 | $3.00 | $2.95 | 279,100 | |
| $2.98 | -0.07 | -2.3% | $3.04 | $3.07 | $2.94 | 411,400 | |
| $3.05 | +0.04 | +1.3% | $3.02 | $3.06 | $2.98 | 618,900 | |
| $3.01 | +0.01 | +0.3% | $2.99 | $3.04 | $2.98 | 381,700 | |
| $3.00 | -0.09 | -2.9% | $3.08 | $3.09 | $3.00 | 390,900 | |
| $3.09 | +0.05 | +1.6% | $3.08 | $3.12 | $3.04 | 476,800 | |
| $3.04 | +0.05 | +1.7% | $2.99 | $3.04 | $2.97 | 292,100 | |
| $2.99 | 0.00 | 0.0% | $2.99 | $3.03 | $2.97 | 609,200 | |
| $2.99 | -0.01 | -0.3% | $2.99 | $3.04 | $2.98 | 217,200 | |
| $3.00 | 0.00 | 0.0% | $3.01 | $3.05 | $2.98 | 340,200 | |
| $3.00 | -0.04 | -1.3% | $3.04 | $3.04 | $2.95 | 573,500 | |
| $3.04 | 0.00 | 0.0% | $3.04 | $3.10 | $3.03 | 420,700 | |
| $3.04 | 0.00 | 0.0% | $3.08 | $3.09 | $3.01 | 321,500 | |
| $3.04 | -0.01 | -0.3% | $3.03 | $3.07 | $3.00 | 276,600 | |
| $3.05 | -0.05 | -1.6% | $3.11 | $3.11 | $3.03 | 362,000 | |
| $3.10 | -0.07 | -2.2% | $3.16 | $3.18 | $3.10 | 531,900 | |
| $3.17 | +0.06 | +1.9% | $3.10 | $3.17 | $3.07 | 256,800 | |
| $3.11 | -0.06 | -1.9% | $3.19 | $3.24 | $3.10 | 242,200 | |
| $3.17 | +0.04 | +1.3% | $3.13 | $3.21 | $3.12 | 308,600 | |
| $3.13 | 0.00 | 0.0% | $3.11 | $3.15 | $3.08 | 283,000 | |
| $3.13 | -0.16 | -4.9% | $3.27 | $3.28 | $3.12 | 477,000 | |
| $3.29 | +0.08 | +2.5% | $3.22 | $3.30 | $3.20 | 498,300 | |
| $3.21 | -0.09 | -2.7% | $3.31 | $3.34 | $3.18 | 466,400 | |
| $3.30 | +0.03 | +0.9% | $3.27 | $3.32 | $3.22 | 385,100 | |
| $3.27 | +0.06 | +1.9% | $3.20 | $3.28 | $3.18 | 242,900 | |
| $3.21 | 0.00 | 0.0% | $3.21 | $3.28 | $3.19 | 415,700 | |
| $3.21 | +0.06 | +1.9% | $3.17 | $3.24 | $3.14 | 370,300 | |
| $3.15 | -0.02 | -0.6% | $3.17 | $3.18 | $3.08 | 431,900 | |
| $3.17 | +0.11 | +3.6% | $3.06 | $3.26 | $3.06 | 806,600 | |
| $3.06 | +0.02 | +0.7% | $3.03 | $3.06 | $3.00 | 518,600 | |
| $3.04 | +0.02 | +0.7% | $3.02 | $3.05 | $2.96 | 622,000 | |
| $3.02 | -0.03 | -1.0% | $3.05 | $3.06 | $2.99 | 390,900 | |
| $3.05 | -0.01 | -0.3% | $3.08 | $3.11 | $3.01 | 344,500 | |
| $3.06 | -0.02 | -0.6% | $3.10 | $3.11 | $3.04 | 395,200 | |
| $3.08 | +0.03 | +1.0% | $3.05 | $3.10 | $2.99 | 555,100 | |
| $3.05 | -0.07 | -2.2% | $3.10 | $3.10 | $2.98 | 754,500 | |
| $3.12 | +0.08 | +2.6% | $3.07 | $3.13 | $2.95 | 889,800 | |
| $3.04 | +0.08 | +2.7% | $3.00 | $3.04 | $2.92 | 703,000 | |
| $2.96 | -0.51 | -14.7% | $3.11 | $3.21 | $2.87 | 1,826,300 | |
| $3.47 | -0.06 | -1.7% | $3.51 | $3.63 | $3.46 | 1,029,800 | |
| $3.53 | +0.13 | +3.8% | $3.50 | $3.58 | $3.43 | 1,263,700 | |
| $3.40 | +0.08 | +2.4% | $3.32 | $3.41 | $3.21 | 648,500 | |
| $3.32 | +0.10 | +3.1% | $3.20 | $3.34 | $3.20 | 575,100 |
- Ticker
- Hamburg:OCD1
- Asset type
- Stock
- Exchange
- Hamburg
- Currency
- EUR
What changed lately
Latest news release · Oct 22, 2026
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Latest earnings call · Aug 4, 2026
Niagen Bioscience (NASDAQ:NAGE) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 4, 2026
Q2 2026 Earnings Presentation
Earnings · 18 slides
Calls
Upcoming
Niagen Bioscience (NASDAQ:NAGE) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Register
Replays
Niagen Bioscience (NASDAQ:NAGE) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptNiagen Bioscience (NASDAQ:NAGE) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptNiagen Bioscience (NASDAQ:NAGE) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Oct 22, 2026
Closed $2.52 (+2.0%) on Oct 22, 2026
Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® Product
Oct 20, 2026
Closed $2.51 (+0.4%) on Oct 20, 2026
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Oct 15, 2026
Closed $2.58 (+2.0%) on Oct 15, 2026
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
Oct 8, 2026
Closed $2.66 (-2.2%) on Oct 8, 2026
Niagen Bioscience to Present at LD Micro 20th Annual Main Event
Oct 6, 2026
Closed $2.69 (+0.4%) on Oct 6, 2026
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®" a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
Oct 1, 2026
Closed $2.68 (-8.2%) on Oct 1, 2026
Niagen Bioscience Announces Start-Up Agreement With Mass General Brigham (MGB) Investigators For First-Of-Its-Kind Healthy Aging Clinical Trial
Sep 30, 2026
Closed $2.92 (-1.0%) on Sep 30, 2026
Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (NR) Improves Pregnancy Outcomes
Sep 21, 2026
Closed $3.04 (+1.7%) on Sep 21, 2026
Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth
Sep 17, 2026
Closed $2.99 (-0.3%) on Sep 17, 2026
Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
Sep 10, 2026
Closed $3.04 (-0.3%) on Sep 10, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 18 slides · Aug 4, 2026
KCSA Strategic Communications Fireside Chat with Rob Fried (July 2026)
Conference · 15 slides · Jul 14, 2026
Q1 2026 Earnings Presentation
Earnings · 19 slides · May 6, 2026
FY2025 Earnings Presentation
Earnings · 21 slides · Mar 4, 2026
Niagen Bioscience, Inc. on 6ix
- News releases
- 50 in the last 12 months · 210 in all · newest Oct 22, 2026 · oldest 2020
- Calls
- 30 calls with a replay · 30 with a transcript · latest Aug 4, 2026
- Decks
- 59 decks · latest Aug 4, 2026
Where Niagen Bioscience, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NAGE · Home listing | NASDAQ | United States | USD |
| gettex:OCD1 | gettex | Germany | EUR |
| LS Exchange:A2AG5N | LS Exchange | Germany | EUR |
| BOATS:NAGE | BOATS | United States | USD |
| Lang & Schwarz:A2AG5N | Lang & Schwarz | Germany | EUR |
| Frankfurt:OCD1 | Frankfurt | Germany | EUR |
| Dusseldorf:OCD1 | Dusseldorf | Germany | EUR |
| Hamburg:OCD1 · This page | Hamburg | Germany | EUR |
| Munich:OCD1 | Munich | Germany | EUR |
| Stuttgart:OCD1 | Stuttgart | Germany | EUR |
| Tradegate:OCD1 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Niagen Bioscience, Inc.